At the end of the latest market close, NeoGenomics Inc. (NEO) was valued at $41.95. In that particular session, Stock kicked-off at the price of $41.33 while reaching the peak value of $41.3783 and lowest value recorded on the day was $38.75. The stock current value is $41.25.
Recently in News on October 27, 2020, NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter. Third-Quarter 2020 Results and Highlights:. You can read further details here
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
NeoGenomics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $44.58 on 10/16/20, with the lowest value was $20.47 for the same time period, recorded on 03/12/20.
NeoGenomics Inc. (NEO) full year performance was 97.75%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NeoGenomics Inc. shares are logging -7.47% during the 52-week period from high price, and 105.82% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $20.04 and $44.58.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1154907 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the NeoGenomics Inc. (NEO) recorded performance in the market was 41.03%, having the revenues showcasing 9.91% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 4.68B, as it employees total of 1700 workers.
NeoGenomics Inc. (NEO) in the eye of market guru’s
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 36.32, with a change in the price was noted +13.71. In a similar fashion, NeoGenomics Inc. posted a movement of +49.78% for the period of last 100 days, recording 779,265 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NEO is recording 0.26 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.25.
NeoGenomics Inc. (NEO): Stocks Technical analysis and Trends
Raw Stochastic average of NeoGenomics Inc. in the period of last 50 days is set at 67.98%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.33%. In the last 20 days, the company’s Stochastic %K was 65.31% and its Stochastic %D was recorded 69.68%.
If we look into the earlier routines of NeoGenomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 41.03%. Additionally, trading for the stock in the period of the last six months notably improved by 32.98%, alongside a boost of 97.75% for the period of the last 12 months. The shares increased approximately by -3.51% in the 7-day charts and went down by 14.08% in the period of the last 30 days. Common stock shares were driven by 9.91% during last recorded quarter.